Omalizumab may facilitate drug desensitization in patients failing standard protocols.

Gemici Karaaslan, Hatice Betul; Karabag Yilmaz, Esra; Gulmez, Ruveyda; Canpolat, Nur; Kiykim, Ayca; Cokugras, Haluk Cezmi

Gemici Karaaslan, Hatice Betul; Karabag Yilmaz, Esra; Gulmez, Ruveyda; Canpolat, Nur; Kiykim, Ayca; Cokugras, Haluk Cezmi.

Afiliación

Gemici Karaaslan HB; Department of Pediatric Immunology and Allergy, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Karabag Yilmaz E; Department of Pediatric Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Gulmez R; Department of Pediatric Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Canpolat N; Department of Pediatric Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Kiykim A; Department of Pediatric Immunology and Allergy, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Cokugras HC; Department of Pediatric Immunology and Allergy, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Pediatr Allergy Immunol ; 33(5): e13783, 2022 05.

Article en En | MEDLINE | ID: mdl-35616895

Asunto(s)

Anafilaxia; Antialérgicos; Hipersensibilidad a las Drogas; Antialérgicos/uso terapéutico; Desensibilización Inmunológica/métodos; Hipersensibilidad a las Drogas/diagnóstico; Hipersensibilidad a las Drogas/terapia; Humanos; Omalizumab/uso terapéutico

Palabras clave

anaphylaxis; children; drug allergy; drug desensitization; hypersensitivity; nephrotic syndrome; omalizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antialérgicos / Hipersensibilidad a las Drogas / Anafilaxia Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Pediatr Allergy Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google